Search Results - "Krag, Aleksander"

Refine Results
  1. 1

    Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure by Trebicka, Jonel, Bork, Peer, Krag, Aleksander, Arumugam, Manimozhiyan

    “…The human gut microbiome has emerged as a major player in human health and disease. The liver, as the first organ to encounter microbial products that cross…”
    Get full text
    Journal Article
  2. 2

    Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care by Blanes-Vidal, Victoria, Lindvig, Katrine P., Thiele, Maja, Nadimi, Esmaeil S., Krag, Aleksander

    Published in Scientific reports (21-02-2022)
    “…For years, hepatologists have been seeking non-invasive methods able to detect significant liver fibrosis. However, no previous algorithm using routine blood…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis by Thiele, Maja, Detlefsen, Sönke, Sevelsted Møller, Linda, Madsen, Bjørn Stæhr, Fuglsang Hansen, Janne, Fialla, Annette Dam, Trebicka, Jonel, Krag, Aleksander

    “…Background & Aims Alcohol abuse causes half of all deaths from cirrhosis in the West, but few tools are available for noninvasive diagnosis of alcoholic liver…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome by Gluud, Lise L., Christensen, Kurt, Christensen, Erik, Krag, Aleksander

    Published in Hepatology (Baltimore, Md.) (01-02-2010)
    “…Vasoconstrictor drugs may improve renal function in hepatorenal syndrome (HRS), but the effect on mortality has not been established. We therefore performed a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis by Fialla, Annette D., Israelsen, Mads, Hamberg, Ole, Krag, Aleksander, Gluud, Lise Lotte

    Published in Liver international (01-09-2015)
    “…Background & Aims Patients with cirrhosis and alcoholic hepatitis are often malnourished and have a superimposed stress metabolism, which increases nutritional…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD by Lindholm, Majken, Godskesen, Line E., Manon-Jensen, Tina, Kjeldsen, Jens, Krag, Aleksander, Karsdal, Morten A., Mortensen, Joachim H.

    Published in Scientific reports (19-07-2021)
    “…In inflammatory bowel disease (IBD), the chronic inflammation deeply affects the intestinal extracellular matrix. The aim of this study was to investigate if…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials by Thiele, Maja, Albillos, Agustín, Abazi, Rozeta, Wiest, Reiner, Gluud, Lise L., Krag, Aleksander

    Published in Liver international (01-08-2015)
    “…Background & Aims Non‐selective beta‐blockers (NSBB) are used in patients with cirrhosis and oesophageal varices. Experimental data suggest that NSBB inhibit…”
    Get full text
    Journal Article
  18. 18

    Alcoholic liver disease: A registry view on comorbidities and disease prediction by Grissa, Dhouha, Nytoft Rasmussen, Ditlev, Krag, Aleksander, Brunak, Søren, Juhl Jensen, Lars

    Published in PLoS computational biology (22-09-2020)
    “…Alcoholic-related liver disease (ALD) is the cause of more than half of all liver-related deaths. Sustained excess drinking causes fatty liver and…”
    Get full text
    Journal Article
  19. 19
  20. 20